Literature DB >> 31046120

Quality of Life in Patients With Olfactory Loss Is Better Predicted by Flavor Identification Than by Orthonasal Olfactory Function.

Anna Oleszkiewicz1,2, Dahae Park1, Katarzyna Resler3, Julia Draf1, Anja Schulze1, Yunpeng Zang1, Antje Hähner1, Thomas Hummel1.   

Abstract

To date, most studies on the relationship between chemosensory performance and quality of life have focused on orthonasal measures of olfactory function. In the current investigation, we examined the predictive value of orthonasal and flavor identification indices of olfactory function on a wide spectrum of health and sociopsychological factors, including quality of life, life satisfaction, overall health, and depressive symptoms. Participants were 178 ENT patients (Mage = 58 ± 1), representing various causes of olfactory loss: idiopathic smell loss (n = 51; Mage = 63 ± 2), sinunasal disease (n = 27; Mage = 56 ± 3), head trauma (n = 33; Mage = 51 ± 2), and infections of the upper respiratory tract (n = 67; Mage = 59 ± 2). They completed self-report questionnaires and underwent olfactory testing using Sniffin' Sticks (orthonasal olfactory testing) and "Taste Powder" (intraorally applied flavors for retronasal olfactory testing, additionally inducing taste sensation). Data were analyzed with hierarchical regression models wherein the first step included subjects' sex, age, and orthonasal olfaction score. In the second step, we included the "Taste Powder" score. Tested models revealed that the first step was not significantly predicting variables of interest; however, there was an improvement of the model's predictive value when the "Taste Powder" score was added. Results of this study suggest that flavor identification significantly improves predictions of health and sociopsychological functioning of ENT patients with various etiologies.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  flavor; olfaction; orthonasal; quality of life; retronasal

Year:  2019        PMID: 31046120     DOI: 10.1093/chemse/bjz027

Source DB:  PubMed          Journal:  Chem Senses        ISSN: 0379-864X            Impact factor:   3.160


  7 in total

Review 1.  Olfaction: Sensitive indicator of inflammatory burden in chronic rhinosinusitis.

Authors:  Xiaoguang Yan; Katherine Lisa Whitcroft; Thomas Hummel
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-10-28

Review 2.  Human olfactory dysfunction: causes and consequences.

Authors:  Laura Schäfer; Valentin A Schriever; Ilona Croy
Journal:  Cell Tissue Res       Date:  2021-01-26       Impact factor: 5.249

3.  Validation study of a novel approach for assessment of retronasal olfactory function with combination of odor thresholds and identification.

Authors:  Ayaho Yoshino; Robert Pellegrino; Curtis R Luckett; Thomas Hummel
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-19       Impact factor: 2.503

4.  q-Powders: a quick test for screening retronasal olfactory disorders with tasteless powders.

Authors:  Michal Pieniak; Anna Oleszkiewicz; Marie Klockow; Ayaho Yoshino; Antje Haehner; Thomas Hummel
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-04       Impact factor: 2.503

Review 5.  Beyond aroma: A scoping review on the impact of chronic rhinosinusitis on retronasal olfaction.

Authors:  Joel James; Ilan C Palte; Brandon J Vilarello; Lucas G Axiotakis; Patricia T Jacobson; David A Gudis; Jonathan B Overdevest
Journal:  Front Allergy       Date:  2022-08-31

6.  Flavor education and training in olfactory dysfunction: a pilot study.

Authors:  Gerold Besser; Michaela M Oswald; David T Liu; Bertold Renner; Christian A Mueller
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-04-04       Impact factor: 2.503

7.  Ortho- and retronasal olfactory performance in rhinosurgical procedures: a longitudinal comparative study.

Authors:  Gerold Besser; David T Liu; Gunjan Sharma; Tina J Bartosik; Sebastian Kaphle; Max Enßlin; Bertold Renner; Christian A Mueller
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-19       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.